Resurgence of Group A Streptococcal Infections

Area of Science:

• Microbiology
• Infectious Diseases
• Public Health

Background:

• Group A Streptococcus (GAS) causes a wide spectrum of diseases, from mild to life-threatening invasive infections.
• Historically, GAS infections declined due to improved living conditions.
• The COVID-19 pandemic has coincided with a resurgence of GAS infections worldwide.

Purpose of the Study:

• To highlight the current global resurgence of Group A Streptococcus (GAS) infections.
• To underscore the growing concern of antimicrobial resistance in GAS.
• To discuss the challenges in developing effective GAS vaccines.

Main Methods:

• Review of recent epidemiological trends in GAS infections.
• Analysis of antimicrobial resistance patterns associated with GAS.
• Assessment of current vaccine development pipelines and associated hurdles.

Main Results:

• A notable increase in GAS cases globally has been observed.
• Rising antimicrobial resistance poses a significant threat to GAS treatment.
• Development of safe and effective GAS vaccines faces substantial obstacles.

Conclusions:

• The resurgence of GAS and increasing antimicrobial resistance necessitate urgent attention.
• Overcoming challenges in vaccine development is critical for future GAS prevention.
• Continued research and public health strategies are essential to manage GAS burden.